A&G PHARMACEUTICAL, INC. Federal Contracts — Government Award History
Total (All Time)$51,483
Latest FY$51,483
Primary AgencyDepartment of Health and Human Services
A&G PHARMACEUTICAL, INC. has received $51,483 in total federal contract awards
across 1 fiscal year(s). Peak year was FY2019 ($51,483).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2019 | $51,483 | 3건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2019-09-16 | Department of Health and Human Services | $23,939 | A&G PHARMACEUTICAL INC:1108556 [19-012522] |
| 2021-08-16 | Department of Health and Human Services | $23,225 | ANTIBODY DEVELOPMENT SERVICES FOR MALARIAL ORGANELLES |
| 2020-06-18 | Department of Health and Human Services | $19,350 | NIH-APPROVED COVID-RELATED PROJECT: ANALYSIS OF A NOVEL TRUNCATED FORM OF ACE2 |
| 2025-03-25 | Department of Health and Human Services | $16,900 | MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND |
| 2024-08-27 | Department of Health and Human Services | $15,500 | PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING |
| 2019-09-13 | Department of Health and Human Services | $15,417 | A&G PHARMACEUTICAL INC:1108556 [19-012467]MONOCLONAL ANTIBODY (MAB) DEVELOPMENT |
| 2022-09-22 | Department of Health and Human Services | $15,125 | CUSTOM MONOCLONAL ANTIBODIES |
| 2025-09-24 | Department of Health and Human Services | $13,600 | TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT. |
| 2019-09-24 | Department of Agriculture | $12,127 | PEPT001 ANTIBODY DEVELOPMENT – PEPTIDE SYNTHESIS PER AMINO ACID. PEPTIDE #1 AND |